# Elizabeth Holmes Under New Scrutiny: Documentary Exposes Theranos Fraud Through Fresh Lens
Nathan Fielder's documentary "You Can See Everything" brings renewed attention to the Elizabeth Holmes fraud case, this time through investigative journalism embedded within the filmmaker's distinctive narrative approach. The project systematically deconstructs Holmes' misleading claims about Theranos, the blood-testing company that collapsed after being exposed as a fraudulent operation.
Holmes founded Theranos in 2003 and built the company into a $9 billion valuation at its peak. She claimed her technology could run hundreds of blood tests from a single finger prick, a technological breakthrough that attracted major investors and partnerships with Walgreens and Safeway. The reality proved far different. Theranos machines produced inaccurate results, the company misled investors about technological capabilities and regulatory approvals, and Holmes personally orchestrated a campaign of deception that fooled Silicon Valley's most prominent venture capitalists.
The original Wall Street Journal investigation by John Carreyrou in 2015 first exposed the fraud. Carreyrou's reporting triggered a cascade of legal consequences. Federal prosecutors charged Holmes with wire fraud and conspiracy in 2018. In January 2022, a jury convicted Holmes on four counts of defrauding investors, though acquitted her on charges related to defrauding patients. She received an 11-year prison sentence.
Fielder's documentary arrives after these legal resolutions, yet serves a distinct purpose. Rather than simply rehashing established facts, the film dissects how Holmes constructed and maintained her deception. The documentary examines the mechanisms of her fraud with precision, showing how she manipulated not just investors but her own board members and employees. This approach differs from traditional true-crime formats by focusing on the architecture of the lie itself.
The timing reflects broader investor interest in understanding how major fraud occurs within the venture capital ecosystem. Theranos became emblematic of Silicon Valley's "fake it till you make it" mentality taken to criminal extremes. The case exposed gaps in venture due diligence, regulatory oversight of private companies, and media credibility during the hype cycle.
Holmes has maintained her innocence throughout legal proceedings and appeals, though her claims have been thoroughly discredited by evidence presented at trial. The documentary offers viewers the opportunity to examine her statements against documented facts, drawing their own conclusions about deliberate deception versus incompetence.
Fielder, known for "Nathan for You," brings his characteristic analytical style to corporate fraud. His approach transforms a familiar financial scandal into something that demands active engagement from viewers. The film functions as both entertainment and education, examining how one person manipulated multiple powerful institutions simultaneously.
The documentary resurfacing the Holmes case occurs during a period when venture capital scrutiny has intensified. Recent startup collapses, including the Sam Bankman-Fried fraud at FTX, have reinforced lessons about the consequences of inadequate investor verification and governance failures.
For investors evaluating private companies and venture opportunities, the Holmes case remains instructive. Documentary evidence of her methods provides a playbook for recognizing similar deceptive tactics in emerging companies making extraordinary claims about untested technology.